Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients

Clinical Trial ID NCT02458417

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02458417

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004 2.87
2 Clinical practice. Vitiligo. N Engl J Med 2009 2.72
3 Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 2011 1.70
4 Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001 1.68
5 Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. J Am Acad Dermatol 1992 1.50
6 Ex vivo histological characterization of a novel ablative fractional resurfacing device. Lasers Surg Med 2007 1.44
7 Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005 1.38
8 Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Arch Dermatol 2004 1.36
9 Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008 1.35
10 A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns. Burns 2007 1.26
11 The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol 2009 1.07
12 Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension. Br J Dermatol 2002 1.07
13 Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus. Br J Dermatol 2010 1.04
14 Surgical techniques for vitiligo: a review. Dermatology 2001 1.02
15 Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 1996 0.97
16 Fractionated CO2 laser resurfacing: our experience with more than 2000 treatments. Aesthet Surg J 2009 0.95
17 Treatment of vitiligo lesions by ReCell vs. conventional melanocyte-keratinocyte transplantation: a pilot study. Br J Dermatol 2007 0.95
18 Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients. J Am Acad Dermatol 1995 0.94
19 Characterisation of the cell suspension harvested from the dermal epidermal junction using a ReCell® kit. Burns 2011 0.90
20 Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients. Dermatology 1999 0.89
21 Grafting and transplantation of melanocytes for repigmenting vitiligo and other types of leukoderma. Int J Dermatol 1989 0.88
22 Guidelines of care for vitiligo. American Academy of Dermatology. J Am Acad Dermatol 1996 0.85
23 Ablative and fractional ablative lasers. Dermatol Clin 2009 0.85
24 Treatment of stable vitiligo hands by ReCell system: a preliminary report. Eur Rev Med Pharmacol Sci 2010 0.81
25 Treatment of stable vitiligo by ReCell system. Acta Dermatovenerol Croat 2009 0.80
26 Melanocyte repopulation in full-thickness wounds using a cell spray apparatus. J Burn Care Rehabil 2001 0.80
27 Complications of resurfacing. Semin Cutan Med Surg 1996 0.79
28 New KIT mutations in patients with piebaldism. J Dermatol Sci 2004 0.79
29 Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity. Br J Dermatol 2009 0.79
30 SilkTouch: a new technology for skin resurfacing in aesthetic surgery. J Clin Laser Med Surg 1995 0.78
31 Vitiligo: concise evidence based guidelines on diagnosis and management. Postgrad Med J 2010 0.76
32 Punchgraft testing in vitiligo; effects of UVA, NB-UVB and 632.8 nm Helium-Neon laser on the outcome. J Eur Acad Dermatol Venereol 2010 0.75
33 Digital image analysis vs. clinical assessment to evaluate repigmentation after punch grafting in vitiligo. J Eur Acad Dermatol Venereol 2012 0.75
Next 100